Economic impact of the use of patiromer in chronic kidney disease or heart failure for the treatment of chronic hyperkalemia in Spain

1. de Sequera, P.
2. Bover, R.
3. Ivanova-Markova, Y.
4. Ivanova, A.
5. González-Domínguez, A.
6. Valls, M.
7. Campos, V.

Exporta

Exporta

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Exporta

×

El document no es pot exportar perquè pertany a un altre portal.

Text complet

lock_openText complet externo

DOI: 10.1016/J.NEFROE.2024.01.002 GOOGLE SCHOLAR lock_openAccés obert editor

Objectius de Desenvolupament Sostenible

• 

Font de les dades: Scopus